Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-03

Clinical Trial Update: Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the abuse liability of oxycodone HCl/niacin in adults with a history of opioid abuse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone HCl/Niacin (oxycodone HCl/niacin)

Snippet

Sponsor: Acura Pharmaceuticals Inc. | Conditions: Opioid Abuse | Phase 2 | Status: COMPLETED | Results posted: 2018-10-03